Promising Rheumatic Drugs Highlight Specialty Pharmacy Week in Review

Top stories of the week on Specialty Pharmacy Times from June 15 to June 19.

Three Value-Based Attributes Payers Should Seek from Pharmacist Partners

Amidst the seismic shift to value-based care, what are the three attributes payers should seek from pharmacist partners?

http://www.specialtypharmacytimes.com/contributor/marc-oconnor/2015/06/three-value-based-attributes-payers-should-seek-from-pharmacist-partners

Moderate or High Rheumatoid Arthritis Disease Activity Carries Same Joint Failure Risk

Either patient group in need of more intensive treatment to reduce surgery risk.

http://www.specialtypharmacytimes.com/news/Moderate-or-High-Rheumatoid-Arthritis-Disease-Activity-Carries-Same-Joint-Failure-Risk

New Drug Review: Raplixa by The Medicines Company, Inc

Raplixa is a new option for stopping bleeding during surgery when standard surgical techniques are ineffective.

http://www.specialtypharmacytimes.com/news/Raplixa-by-The-Medicines-Company-Inc

Rheumatoid Arthritis Drug Awarded Breakthrough Status for Systemic Sclerosis

Drug shows improvement in skin thickening with active treatment.

http://www.specialtypharmacytimes.com/news/Rheumatoid-Arthritis-Drug-Awarded-Breakthrough-Status-for-Systemic-Sclerosis

Pharmacists Need to Weigh Cost—Benefit of Hepatitis C Drugs

The total cost of health must be considered in light of a potential cure.

http://www.specialtypharmacytimes.com/news/Pharmacists-Need-to-Weigh-Cost-Benefit-of-Hepatitis-C-Drugs

New Psoriasis Drug Shows Complete Symptom Clearance

Physical aspects and quality of life issues improve with treatment.

http://www.specialtypharmacytimes.com/news/New-Psoriasis-Drug-Shows-Complete-Symptom-Clearance

Lung Cancer Drug Extends Survival

Necitumumab added to chemotherapy increases survival to nearly a year.

http://www.specialtypharmacytimes.com/news/Lung-Cancer-Drug-Extends-Survival

The Search for New Inflammatory Bowel Disease Treatment Targets

Modifying small white blood cells shows promise in treating immune disorders.

http://www.specialtypharmacytimes.com/news/The-Search-for-New-Inflammatory-Bowel-Disease-Treatment-Targets

Avocados May Prove to be Cancer Fighter

Lipid from avocados targets leukemia stem cells.

http://www.specialtypharmacytimes.com/news/Avocados-May-Prove-to-be-Cancer-Fighter

Aggressive Combination Therapy Improves RA Disease Severity

Patients achieve drug-free remission with less expensive biologic drugs during first 2 years of treatment.

http://www.specialtypharmacytimes.com/news/Aggressive-Combination-Therapy-Improves-RA-Disease-Severity